Valuation: Cipla Limited

Market Cap 1,14000Cr 1.18TCr 1.04TCr 966.54Cr 886.92Cr 1.67TCr 1.69TCr 11TCr 4.48TCr 56TCr 4.44TCr 4.35TCr 1,93700Cr P/E 2027 *
27.4x
P/E 2028 * 22.1x
Enterprise Value 1,03300Cr 1.07TCr 942.56Cr 876.56Cr 804.36Cr 1.51TCr 1.53TCr 10TCr 4.07TCr 51TCr 4.03TCr 3.94TCr 1,75700Cr EV / Sales 2027 *
3.33x
EV / Sales 2028 * 2.9x
Free-Float
68.88%
Yield 2027 *
0.9%
Yield 2028 * 1.02%
1 day-0.09%
1 week-2.23%
Current month-3.82%
1 month-3.07%
3 months+7.00%
6 months+7.34%
Current year-6.74%
1 week 1,366.1
Extreme 1366.1
1,444.8
1 month 1,366.1
Extreme 1366.1
1,490.1
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
President - 18/05/2026
Director of Finance/CFO - 24/07/2026
Director TitleAgeSince
Chairman 90 21/07/1972
Director/Board Member 72 25/07/2014
Director/Board Member 71 30/06/2021
Date Insider Type Main position Quantity % Market Cap.
22/08/24 Sell 2,000 0.0002%
14/08/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.09%-2.23%-10.34%+20.31% 1.18TCr
+1.68%+0.88%+15.95%+73.90% 4.84TCr
+1.52%+2.21%+61.55%+111.64% 3.58TCr
-0.05%-3.55%+13.07%+70.62% 1.15TCr
-0.28%-0.37%+37.53%+142.08% 901.45Cr
+0.18%+1.77%+47.40%-8.43% 698.99Cr
+1.46%-1.01%+13.01%+33.60% 669.73Cr
+0.18%-1.94%+2.41%+167.04% 642.34Cr
-7.92%-13.61%-33.87%-3.30% 529.99Cr
+0.49%-2.39%+22.37%+118.10% 436.97Cr
Average -0.27%-2.05%+16.91%+72.56% 1.46TCr
Weighted average by Cap. +0.71%-0.48%+25.25%+79.58%

Financials

2027 *2028 *
Net sales 31TCr 321.88Cr 282.71Cr 262.91Cr 241.26Cr 453.3Cr 460.29Cr 3.12TCr 1.22TCr 15TCr 1.21TCr 1.18TCr 53TCr 35TCr 360.59Cr 316.71Cr 294.53Cr 270.27Cr 507.82Cr 515.65Cr 3.5TCr 1.37TCr 17TCr 1.35TCr 1.32TCr 59TCr
Net income 4.15TCr 43Cr 38Cr 35Cr 32Cr 61Cr 62Cr 418.08Cr 163.34Cr 2.04TCr 161.81Cr 158.33Cr 7.06TCr 5.15TCr 54Cr 47Cr 44Cr 40Cr 75Cr 77Cr 518.94Cr 202.74Cr 2.53TCr 200.85Cr 196.52Cr 8.76TCr
Net Debt -11TCr -110.16Cr -97Cr -90Cr -83Cr -155.14Cr -157.53Cr -1.07TCr -417.44Cr -5.22TCr -413.54Cr -404.62Cr -18TCr -13TCr -136.48Cr -119.87Cr -111.48Cr -102.3Cr -192.21Cr -195.17Cr -1.32TCr -517.19Cr -6.46TCr -512.35Cr -501.31Cr -22TCr
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
27/26/27 1,409.40 -0.09% 11,62,030
24/26/24 ₹1,410.60 +1.26% 29,17,791
23/26/23 ₹1,393.00 -1.56% 42,48,433
22/26/22 ₹1,415.10 -1.21% 17,22,239
21/26/21 ₹1,432.50 -0.63% 13,41,452
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,410.60INR
Average target price
1,513.00INR
Spread / Average Target
+7.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock